ArticleJournal of neuroscience research2026
Loss of Neocortical Oligodendrocytes in Parkinson's Disease Patients-A Stereological Study.
Article in Journal of neuroscience research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Parkinson's disease (PD) is a neurodegenerative disorder, clinically characterized by motor- and non-motor symptoms. Misfolding of alpha-synuclein into pathological substrates, followed by neuronal spread, seems to be a key event in the spatiotemporal course of the disease. Previously, few studies have yielded insight into altered cell numbers in post-mortem brains from PD patients. Beside nigral neuronal loss, no quantitative studies have reported significant loss of neurons in PD brains, suggesting that the neuropathological progress in PD have minor impact on neuronal survival outside of the substantia nigra. Reports further show impairment of intra- and inter-cortical white matter tracts, observations that signify a role of oligodendrocytes in PD pathogenesis. Hence, our objective of the present study was to investigate oligodendroglia morphology (total numbers and volumes) in the neocortex of post-mortem brains from PD patients and control subjects using stereological methods. Our findings show an explicit 34% reduction in the total number of oligodendrocytes in the frontal cortex of PD patients, with no such changes in the other cortical lobes. Furthermore, the results displayed no group differences in the mean volume of oligodendrocytes in the entire neocortex or its subregions. The reduction in frontal oligodendrocytes may be related to the demonstrated impairment of white matter tracts, however, further studies are needed to clarify the mechanistic and functional relevance of oligodendropathy in PD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.